US banks face capital hit from resurgent advanced approaches

Banks pushed onto internal models wrestle with procyclical capital charges


With the coronavirus crisis rattling markets and undermining the creditworthiness of even rock-solid firms, US banks have seen risks gauged using their own models leap higher relative to regulator-set standardised measures. Given that the latter are far clunkier than banks’ internal indicators and respond more slowly to changing credit conditions, this could have wide-ranging implications for capital allocation.

As of end-March, three systemically important US banks – Citi, Goldman Sachs and

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: